PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+13.1%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$289M
AUM Growth
+$289M
(+48%)
Cap. Flow
+$84.1M
Cap. Flow
% of AUM
29.12%
Top 10 Holdings %
Top 10 Hldgs %
31.45%
Holding
95
New
31
Increased
23
Reduced
9
Closed
17
Top Buys
| 1 |
Exact Sciences
EXAS
|
$8.27M |
| 2 |
GSK
GSK
|
$8.25M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$8.18M |
| 4 |
Centene
CNC
|
$7.73M |
| 5 |
Revvity
RVTY
|
$6.94M |
Top Sells
| 1 |
ATHN
Athenahealth, Inc.
ATHN
|
$9.99M |
| 2 |
iShares Europe ETF
IEV
|
$7.22M |
| 3 |
NUVA
NuVasive, Inc.
NUVA
|
$7.07M |
| 4 |
Humana
HUM
|
$6.84M |
| 5 |
AET
Aetna Inc
AET
|
$4.84M |
Sector Composition
| 1 | Healthcare | 86.67% |
| 2 | Financials | 0% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Hologic
HOLX
$14.9B
| $10.7M | 3.18% | 252,500 +38,075 | +18% | +$1.62M |
|
2
Bio-Rad Laboratories Class A
BIO
$8.06B
| $10.6M | 3.12% | 53,000 +22,500 | +74% | +$4.49M |
|
3
Baxter International
BAX
$12.7B
| $9.34M | 2.76% | 180,000 +30,000 | +20% | +$1.56M |
|
|
BCR
4
DELISTED
CR Bard Inc.
BCR
| $9.32M | 2.76% | 37,500 +1,000 | +3% | +$249K |
|
5
Boston Scientific
BSX
$156B
| $9.08M | 2.68% | 365,000 -15,000 | -4% | -$373K |
|
|
EVHC
6
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $8.59M | 2.54% | 140,000 -1,644 | -1% | -$101K |
|
7
Globus Medical
GMED
$8.27B
| $8.46M | 2.5% | 285,646 +85,646 | +43% | +$2.54M |
|
|
8
Exact Sciences
EXAS
$8.98B
| $8.27M | 2.44% | +350,000 | New | +$8.27M |
|
|
9
GSK
GSK
$79.9B
| $8.25M | 2.44% | +195,625 | New | +$8.25M |
|
|
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $8.18M | 2.42% | +67,500 | New | +$8.18M |
|
11
UnitedHealth
UNH
$281B
| $7.79M | 2.3% | 47,500 -15,000 | -24% | -$2.46M |
|
|
12
Centene
CNC
$14.3B
| $7.73M | 2.29% | +108,491 | New | +$7.73M |
|
13
ICU Medical
ICUI
$3.15B
| $7.64M | 2.26% | 50,000 +27,500 | +122% | +$4.2M |
|
|
NXTM
14
DELISTED
NxStage Medical Inc.
NXTM
| $7.38M | 2.18% | 275,000 +17,500 | +7% | +$470K |
|
|
15
Revvity
RVTY
$10.5B
| $6.94M | 2.05% | +119,500 | New | +$6.94M |
|
|
AGN
16
DELISTED
Allergan plc
AGN
| $6.9M | 2.04% | 28,875 +22,175 | +331% | +$5.3M |
|
17
Abbott
ABT
$231B
| $6.88M | 2.04% | +155,000 | New | +$6.88M |
|
18
Universal Health Services
UHS
$11.6B
| $6.85M | 2.02% | +55,000 | New | +$6.85M |
|
|
SHPG
19
DELISTED
Shire pic
SHPG
| $6.82M | 2.02% | +39,125 | New | +$6.82M |
|
|
XENT
20
DELISTED
Intersect ENT, Inc
XENT
| $6.65M | 1.97% | +387,922 | New | +$6.65M |
|
|
IVC
21
DELISTED
Invacare Corporation
IVC
| $6.25M | 1.85% | 525,010 +301,571 | +135% | +$3.59M |
|
22
Teleflex
TFX
$5.59B
| $5.81M | 1.72% | +30,000 | New | +$5.81M |
|
|
SIOX
23
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $5.68M | 1.68% | +380,000 | New | +$5.68M |
|
|
AVXS
24
DELISTED
AveXis, Inc. Common Stock
AVXS
| $5.52M | 1.63% | 72,625 +20,250 | +39% | +$1.54M |
|
|
CELG
25
DELISTED
Celgene Corp
CELG
| $5.48M | 1.62% | +44,000 | New | +$5.48M |
|